Yale Cancer Center receives funding to increase access to early phase clinical trials

Yale Cancer Center is pleased to announce collaborative funding to support and increase access to early phase clinical trials for patients at community sites for cancer care in Connecticut.

Related Keywords

Connecticut ,United States ,Patriciam Lorusso ,Emily Henderson ,Cancer Research Industry ,Smilow Cancer Hospital Care Center ,Gilead Sciences ,Genentech ,Yale Cancer Center ,Experimental Therapeutics At Yale Cancer Center ,Boehringer Ingelheim ,Cancer Center ,Cancer Research ,Roche Group ,Yale Cancer Center Consortium ,Advance Equity ,Early Phase Clinical Trials ,Early Phase Clinical Trials Program ,Research Industry Focus ,Medical Oncology ,Associate Cancer Center Director ,Experimental Therapeutics ,Smilow Cancer ,Cancer ,Clinical Trial ,Hospital ,Medicine ,Research ,